Stratec (ETR:SBS) Shares Up 7.4% – What’s Next?

Stratec SE (ETR:SBS)’s stock price shot up 7.4% during mid-day trading on Monday . The company traded as high as €19.94 and last traded at €19.84. 9,445 shares changed hands during mid-day trading, an increase of 51% from the average session volume of 6,253 shares. The stock had previously closed at €18.48.

Stratec Trading Up 1.6%

The business has a 50 day simple moving average of €19.08 and a 200-day simple moving average of €21.92. The company has a current ratio of 4.19, a quick ratio of 1.65 and a debt-to-equity ratio of 55.08. The stock has a market capitalization of $239.79 million, a price-to-earnings ratio of 23.95, a price-to-earnings-growth ratio of 10.43 and a beta of 0.72.

Stratec Company Profile

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.